Compare GRFS & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | GOLF |
|---|---|---|
| Founded | 1940 | 1910 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.9B |
| IPO Year | N/A | 2016 |
| Metric | GRFS | GOLF |
|---|---|---|
| Price | $8.27 | $95.96 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 7 |
| Target Price | $10.15 | ★ $83.67 |
| AVG Volume (30 Days) | ★ 573.0K | 220.2K |
| Earning Date | 07-28-2022 | 05-06-2026 |
| Dividend Yield | ★ 1.80% | 1.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $1,633,721,000.00 |
| Revenue This Year | $4.49 | $5.76 |
| Revenue Next Year | $6.42 | $2.44 |
| P/E Ratio | ★ $18.67 | $30.82 |
| Revenue Growth | N/A | ★ 4.71 |
| 52 Week Low | $7.08 | $64.59 |
| 52 Week High | $11.14 | $104.81 |
| Indicator | GRFS | GOLF |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 47.32 |
| Support Level | $7.64 | $90.53 |
| Resistance Level | $8.88 | $103.88 |
| Average True Range (ATR) | 0.18 | 2.85 |
| MACD | -0.02 | -0.30 |
| Stochastic Oscillator | 38.54 | 12.96 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.